BREAKING: The #FDA has approved datopotamab deruxtecan (Dato-DXd) for the treatment of patients with unresectable or metastatic HR+/HER2- breast cancer who have received prior systemic therapy. #bcsm www.targetedonc.com/view/fda-app...

Trading pipettes for paintbrushes and lab coats for aprons—our Christmas lab outing was all about pottery, painting, and pizza

Congrats to Myra Castel on passing her viva and obtaining her PhD! It was a pleasure to supervise the project funded through our @researchireland.bsky.social ACORN project. Thanks to the co-supervisory panel members @neilconlon.bsky.social, Dr Naomi Walsh, Prof John Crown @dcu-lsi.bsky.social